Brains Bioceutical Archives

Home / Posts tagged Brains Bioceutical

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare

Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection SANDWICH, United Kingdom, Aug. 22, 2024 (Korea Bizwire) – Brains Bioceutical Corp. (BBC) has achieved a groundbreaking milestone by submitting one of the world’s first CEP (Certification of Suitability) application [...]

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (Korea Bizwire) – Today marks a pivotal development for Brains Bioceutical Corp (“Brains Bio”), as it significantly strengthens its Veterinary Health Division. This enhancement is led by John Boshart, a distinguished figure in animal health with profound experience from his tenures at Pfizer Animal Health and Zoetis. His arrival [...]

Brains Bioceutical Corp, the Global Leader in Natural Cannabinoid APIs, Introduces Revolutionary Solid THC, Ushering in a New Era of Clinical Research

Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry. Vancouver, Canada & London, United Kingdom, March 05, 2024 (Korea Bizwire) — Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based pharmaceutical industry, is proud to announce [...]